Pay in 4 interest-free payments of $7.13 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
Lower doses of GLP-1 resulted in lower rate of observable side effects based on a sample of 9,528 Microdose GLP-1 Rx Program users
Frequently Asked Questions What makes retatrutide a triple hormone receptor agonist
How much does compounded semaglutide cost monthly with PlexusDx, and does price change if I need higher doses
This unique triple-action mechanism sets it apart from approved medicines such as semaglutide and tirzepatide, and has generated significant scientific interest following promising Phase 2 trial results
The combined action aims to deliver more robust and sustained weight loss and glycemic improvement in patients with T2D and obesity Clinical Evidence: DREAMS-3 DREAMS-3 (NCT06184568) is a multi-center, randomized, open-label phase 3 trial the first globally to compare a GLP-1/GCG dual agonist head-to-head against semaglutide in T2D care
